Answers are grounded in this paper and cite their sources.
Scores of animals have been patented since Harvard claimed the OncoMouse in 1988, creating big headaches for suppliers over the fine print in conditions that have been placed on who could or could not receive animals from their repositories. Now Merck and the National Institutes of Health are funding patent-free mice, which could soon make it easier for all researchers to get access to transgenic mice.
No takes yet. Share an insight, caveat, or question.
Eliot Marshall (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: